학술논문
PIN51 - Cost-Effectiveness Analysis Of Daclatasvir/Sofosbuvir (DCV/SOF) For The Treatment Of HCV Patients Who Failed After First Line Treatment With Second Generation Of Daa In Italy
Document Type
Abstract
Author
Source
In Value in Health October-November 2017 20(9):A787-A788
Subject
Language
ISSN
1098-3015